TABLE 2.
Model for leptin-deficient state | ||
Independent variable | Coefficient* ± SE | P |
Intercept | 1.989 ± 2.859 | 0.49 |
Lean body mass (g) | 0.212 ± 0.281 | 0.46 |
Fat mass (g) | 0.120 ± 0.106 | 0.27 |
Model for leptin-replaced state | ||
Intercept | −4.229 ± 4.499 | 0.36 |
Leptin (ng/ml) | 0.115 ± 0.042 | 0.01 |
Lean body mass (g) | 0.912 ± 0.373 | 0.02 |
Fat mass (g) | −0.086 ± 0.122 | 0.49 |
*Estimated change in mean EE per unit change in the independent variable. Separate models were fit within each state. Interpretation: Plasma leptin level and LBM are significant independent determinants of EE in ob/ob mice receiving short-term leptin replacement in the physiological range. In addition to being significant in the leptin-replaced state, the estimated EE cost per gram increase in LBM is over fourfold larger than it was in the leptin-deficient state. By comparison, the contribution of FM to EE in ob/ob mice did not achieve significance in either the presence or absence of leptin administration.